The full version of the Global Alliance’s Scientific Blueprint for TB Drug Development was published as a supplement to the journal Tuberculosis (Harcourt Publishing).
The Blueprint identifies TB’s scientific challenges and recommends ways to fill the drug development gaps while investigating research and development opportunities. It serves as guide for the TB Alliance and researchers around the world by describing desirable drug candidates and outlining how to develop a new TB drug faster.